Royal Bank of Canada’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-526
| Closed | -$3K | – | 7271 |
|
|
2023
Q3 | $3K | Sell |
526
-260
| -33% | -$1.48K | ﹤0.01% | 6257 |
|
|
2023
Q2 | $3K | Buy |
786
+743
| +1,728% | +$2.84K | ﹤0.01% | 6365 |
|
|
2023
Q1 | $0 | Buy |
43
+29
| +207% | – | ﹤0.01% | 7276 |
|
|
2022
Q4 | $0 | Buy |
+14
| New | – | ﹤0.01% | 7534 |
|
|
2021
Q3 | – | Sell |
-301
| Closed | -$24K | – | 7413 |
|
|
2021
Q2 | $24K | Buy |
301
+249
| +479% | +$19.9K | ﹤0.01% | 5984 |
|
|
2021
Q1 | $7K | Buy |
52
+19
| +58% | +$2.56K | ﹤0.01% | 6467 |
|
|
2020
Q4 | $5K | Buy |
33
+15
| +83% | +$2.27K | ﹤0.01% | 6131 |
|
|
2020
Q3 | $2K | Sell |
18
-1
| -5% | -$111 | ﹤0.01% | 5862 |
|
|
2020
Q2 | $2K | Sell |
19
-1
| -5% | -$105 | ﹤0.01% | 5862 |
|
|
2020
Q1 | $1K | Sell |
20
-39
| -66% | -$1.95K | ﹤0.01% | 6045 |
|
|
2019
Q4 | $17K | Buy |
59
+40
| +211% | +$11.5K | ﹤0.01% | 5332 |
|
|
2019
Q3 | $3K | Sell |
19
-4
| -17% | -$632 | ﹤0.01% | 5576 |
|
|
2019
Q2 | $9K | Buy |
23
+5
| +28% | +$1.96K | ﹤0.01% | 5217 |
|
|
2019
Q1 | $8K | Sell |
18
-5
| -22% | -$2.22K | ﹤0.01% | 5199 |
|
|
2018
Q4 | $10K | Sell |
23
-6
| -21% | -$2.61K | ﹤0.01% | 5121 |
|
|
2018
Q3 | $20K | Buy |
29
+10
| +53% | +$6.9K | ﹤0.01% | 5082 |
|
|
2018
Q2 | $13K | Buy |
+19
| New | +$13K | ﹤0.01% | 5161 |
|